仙琚制药：公司自上市以来一直以稳定的分红方案持续回报广大股东

Core Viewpoint - Xianju Pharmaceutical (002332) has consistently provided stable dividends to shareholders since its listing, with a total dividend payout of 1.187 billion yuan over the first five years and 890 million yuan in the last three years [1] Dividend Policy - The company plans to distribute a cash dividend of 1 yuan (including tax) for every 10 shares based on a total share capital of 989,204,866 shares, amounting to a total payout of approximately 98.92 million yuan for the first half of 2025 [1] - This decision aligns with the guidance from the China Securities Regulatory Commission, which encourages companies to provide stable and reasonable returns to investors while ensuring normal operations and long-term development [1] Future Outlook - The company emphasizes its commitment to long-term and sustainable development, as well as balancing immediate and long-term interests of shareholders, in accordance with its shareholder return plan for the next three years (2024-2026) [1]